Patiromer for Treatment of Hyperkalaemia in Children Under 12 Years of Age
NCT05766839
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
32
Enrollment
INDUSTRY
Sponsor class
Conditions
Hyperkalemia
Interventions
DRUG:
Patiromer
Sponsor
Vifor Pharma, Inc.